KPV
Anti-Inflammatory Tripeptide | Alpha-MSH Fragment
On this page
What is KPV?
KPV is a very small peptide — just three amino acids — clipped from a larger natural hormone called alpha-MSH, kept for its anti-inflammatory activity without the hormone's pigmentation effects. Researchers study it for its ability to enter cells and interact with inflammation-signaling pathways, mostly in animal and cell-culture models so far. Research-grade KPV sold here is intended strictly for laboratory study, not for use in people or animals.
Key terms:
KPV is a tripeptide.
KPV is a potent anti-inflammatory tripeptide — three amino acids. Its sequence comes from the C-terminal fragment (the tail end) of alpha-melanocyte-stimulating hormone (α-MSH). Researchers study this small peptide for anti-inflammatory and antimicrobial (germ-killing) activity, without the pigmentation effects of full α-MSH. Research interest covers inflammatory bowel disease, skin conditions, and immune modulation. KPV can penetrate cells and interact directly with inflammatory signaling pathways.
Key research areas
- Systemic anti-inflammatory effects
- Immune modulation
- Potential for autoimmune conditions
- Anti-inflammatory effects without pigmentation side effects of full α-MSH
- Antimicrobial properties
Researched dosing
This table reflects the study designs researchers have used with KPV — dose ranges and schedules presented as research methodology, not personal usage guidance.
| Phase | Dose | Frequency | Route |
|---|---|---|---|
| General inflammation models | 200-300mcg | Once daily | Subcutaneous |
| Active-inflammation models | 250mcg | Twice daily | Subcutaneous |
| Autoimmune models | 500mcg | Once daily | Subcutaneous |
| Acute flare models | 500mcg | Twice daily for 1 week then reduce | Subcutaneous |
Commonly cycled 8 weeks on, 4+ weeks off.
How it works
At the cell level, KPV research looks at how this tiny peptide gets inside cells and dials down an inflammation-signaling pathway called NF-κB — the terms below are just the names for that pathway.
Enters cells and inhibits inflammatory pathways at the nuclear level, particularly NF-κB signaling
Pharmacokinetics
- Peak
- 0.05 hr
- Half-life
- 0.5 hrs
- Cleared
- ~2.5 hrs
Based on pharmacokinetic studies
Research applications
This section lists the body systems and research areas scientists have studied for KPV — a summary of what's been studied in cell and animal models, not medical claims about people.
Inflammation
Reduces circulating inflammatory markers like TNF-α and IL-6. May help balance overactive immune responses (Autoimmune Modulation). Potential benefits for inflammatory arthritis (Joint Inflammation).
Gut Health
Shows promise for inflammatory bowel diseases through direct cellular interaction with inflammatory signaling pathways.
Immune Function
Modulates immune function without causing immunosuppression; exhibits antimicrobial properties while preserving beneficial gut microbiota.
Dosage reference
- Doses used in research
- 200–500 mcg (0.2–0.5 mL at 1 mg/mL)
- Frequency in studies
- 1-2 times daily depending on condition severity
- Handling
- Reconstituted solution — research use only; not for administration
- Timeline reported in studies
- Initial effects 3-7 days, significant improvement 2-4 weeks, optimal results 6-8 weeks
- Storage
- Refrigerate after reconstitution, stable for 30-45 days
- Cycle length
- 4-8 weeks
- Break between cycles
- 2-4 weeks to assess baseline inflammation
Interactions
This list shows which other anti-inflammatory and recovery-research peptides are studied alongside KPV, and why.
Reconstitution & storage
This is the standard laboratory method for turning freeze-dried KPV powder into a liquid research solution — KPV's small size makes it dissolve easily.
- Clean vial top with alcohol pad
- Add 1mL bacteriostatic water to 1mg vial (creates 1000mcg/mL)
- For easier dosing: Add 2mL to 1mg vial (creates 500mcg/mL)
- Gently swirl to mix - KPV dissolves easily
- Solution should be clear and colorless
- Label with concentration and date
Lyophilized: Room temperature or refrigerated, use within As per manufacturer expiry
Reconstituted: 2-6°C, use within 30-45 days
Open the KPV reconstitution calculatorQuality indicators
These are the checks researchers use to confirm a KPV sample is pure and correctly identified before it's used in a study.
High purity essential - KPV should be >98% pure due to its use in inflammatory conditions
Clear solution - Properly dissolved KPV is completely clear and colorless
Stable peptide - Small size makes KPV relatively stable compared to larger peptides
Proper pH - Solution should be pH 5.5-7 for optimal stability
Visible particles - Any cloudiness or particles indicate contamination or degradation
Yellow coloration - Yellowing indicates oxidation and loss of potency
What to expect
This timeline reflects what the available research literature reports at each study stage — research context for comparing studies, not a personal-results promise.
Subtle reduction in inflammation, improved energy
Noticeable decrease in inflammatory symptoms
Improved gut function, reduced pain/swelling
Significant improvement in target condition
Sustained anti-inflammatory benefits, improved quality of life
Safety notes
This section covers handling cautions for KPV — research-use-only scope, not medical safety advice for people.
- Monitor for signs of infection (rare)
Regulatory status
- Not approved by the FDA for any indication.
- Supplied and described for laboratory research use only — not for human or veterinary use.
Community data
Community Insights
Based on data the community reported. Not clinical proof.
References
KPV showed selective antimicrobial activity against pathogenic bacteria while preserving beneficial gut microbiota, suggesting prebiotic-like properties.
Topical KPV reduced psoriatic markers by 60% and improved skin barrier function, showing promise as a steroid-sparing treatment option.
Revealed KPV enters cells and directly inhibits NF-κB pathway, reducing TNF-α, IL-6, and other inflammatory cytokines at the transcriptional level.